During the past decade, Klinik Löwenstein conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinik Löwenstein" #1 sponsor was "Celgene" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "AIO-Studien-gGmbH" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinik Löwenstein" #1 collaborator was "Roche Pharma AG" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BeiGene" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Klinik Löwenstein" are "Carcinoma, Non-Small-Cell Lung" (7 trials), "Non-Small Cell Lung Cancer" (3 trials), "Idiopathic Pulmonary Fibrosis" (2 trials), "Large Cell Lung Carcinoma Metastatic" (2 trials) and "Lung Adenocarcinoma Metastatic" (2 trials). Many other conditions were trialed in "Klinik Löwenstein" in a lesser frequency.

Most popular intervention types in "Klinik Löwenstein" are "Drug" (19 trials), "Other" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Carboplatin" (3 trials), "Cisplatin" (3 trials), "Gemcitabine" (3 trials) and "Vinorelbine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Klinik Löwenstein" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Klinik Löwenstein". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Klinik Löwenstein, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Klinik Löwenstein, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".